Inovio Pharmaceuticals, Inc. (INO), Thursday announced the pricing of an offering of approximately 14.3 million shares of its common stock and accompanying Series A and Series B warrants, all priced at $1.75 per share.
In addition to the offering, expected to raise around $25 million, the company has also announced a 30-day option to purchase upto about 2.1 million shares along with Series A and Series B warrants.
The offering is set to close on or about July 7, 2025.
In the pre-market hours, INO is moving down 21.96 percent, to $1.67 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.